Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah D de Ferranti

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
The Medical Clinics of North America|March 7, 2012
Childhood cholesterol disorders: the iceberg base or nondisease?Sarah D de Ferranti
Clinical Chemistry|May 22, 2010
Recovery from metabolic syndrome is both possible and beneficialSarah D de Ferranti
Journal of Clinical Lipidology|September 8, 2015
Familial hypercholesterolemia in children and adolescents: A clinical perspectiveSarah D de Ferranti
The New England Journal of Medicine|September 30, 2020
Evolocumab in Children with Heterozygous Familial HypercholesterolemiaSarah D de Ferranti
JAMA|August 9, 2012
Declining cholesterol levels in US youths: a reason for optimismSarah D de Ferranti
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 16, 2007
C-reactive protein: a nontraditional serum marker of cardiovascular riskSarah D de Ferranti, Nader Rifai
Circulation|July 30, 2019
Wearable Biosensors in Pediatric Cardiovascular DiseaseAnimesh Tandon, Sarah D de Ferranti
Pediatric Clinics of North America|September 5, 2020
Update on Preventive CardiologySarah B Clauss, Sarah D de Ferranti
JAMA Network Open|October 31, 2022
Prevalence of High Blood Pressure Among Youth in India and Association With Future Cardiovascular DiseaseAbbas H Zaidi, Sarah D de Ferranti
Evidence-Based Medicine|August 19, 2017
USPSTF is unable to recommend for or against lipid screening to identify multifactorial dyslipidaemia in childhood: no recommendation is not without consequencesSarah D de Ferranti, Radley C Sheldrick
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
The Medical Clinics of North America|March 7, 2012
Childhood cholesterol disorders: the iceberg base or nondisease?Sarah D de Ferranti
Clinical Chemistry|May 22, 2010
Recovery from metabolic syndrome is both possible and beneficialSarah D de Ferranti
Journal of Clinical Lipidology|September 8, 2015
Familial hypercholesterolemia in children and adolescents: A clinical perspectiveSarah D de Ferranti
The New England Journal of Medicine|September 30, 2020
Evolocumab in Children with Heterozygous Familial HypercholesterolemiaSarah D de Ferranti
JAMA|August 9, 2012
Declining cholesterol levels in US youths: a reason for optimismSarah D de Ferranti
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 16, 2007
C-reactive protein: a nontraditional serum marker of cardiovascular riskSarah D de Ferranti, Nader Rifai
Circulation|July 30, 2019
Wearable Biosensors in Pediatric Cardiovascular DiseaseAnimesh Tandon, Sarah D de Ferranti
Pediatric Clinics of North America|September 5, 2020
Update on Preventive CardiologySarah B Clauss, Sarah D de Ferranti
JAMA Network Open|October 31, 2022
Prevalence of High Blood Pressure Among Youth in India and Association With Future Cardiovascular DiseaseAbbas H Zaidi, Sarah D de Ferranti
Evidence-Based Medicine|August 19, 2017
USPSTF is unable to recommend for or against lipid screening to identify multifactorial dyslipidaemia in childhood: no recommendation is not without consequencesSarah D de Ferranti, Radley C Sheldrick
Pageof 16